Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

Association ofGSK-3βGenetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia

(2013) Giuseppe Blasi et al.   AMERICAN JOURNAL OF PSYCHIATRY

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

(2013) Stephan Ripke et al.   NATURE GENETICS

Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene With Prefrontal Function and Olanzapine Treatment

(2013) Giuseppe Blasi et al.   JAMA Psychiatry

Response to Warner Letter

(2012) Fengyu Zhang et al.   AMERICAN JOURNAL OF PSYCHIATRY

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction

(2012) M Ayalew et al.   MOLECULAR PSYCHIATRY

Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

(2012) A. de Bartolomeis et al.   PSYCHOPHARMACOLOGY

A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health

(2011) Jean-Martin Beaulieu   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors

(2011) Laura Albizu et al.   NEUROPHARMACOLOGY

Polymorphisms of the 5-HT2A Receptor Gene and Clinical Response to Olanzapine in Paranoid Schizophrenia

(2011) Luiza Olajossy-Hilkesberger et al.   NEUROPSYCHOBIOLOGY

Genetic Variation of the Serotonin 2a Receptor Affects Hippocampal Novelty Processing in Humans

(2011) Björn H. Schott et al.   PLoS One

Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results

(2011) A. L. Collins et al.   PSYCHOLOGICAL MEDICINE

Role of Serotonin in Central Dopamine Dysfunction

(2010) Giuseppe Di Giovanni et al.   CNS Neuroscience & Therapeutics

Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition

(2010) Roberta Rasetti et al.   NEUROPSYCHOPHARMACOLOGY

DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia

(2010) G. Blasi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nonlinear Response of the Anterior Cingulate and Prefrontal Cortex in Schizophrenia as a Function of Variable Attentional Control

(2009) G. Blasi et al.   CEREBRAL CORTEX

A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia

(2009) Stephen J Huffaker et al.   NATURE MEDICINE

The genetics of schizophrenia

(2009) A. Bertolino et al.   NEUROSCIENCE

HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients

(2009) Shih-Fen Chen et al.   PSYCHOPHARMACOLOGY

No Significant Association of 14 Candidate Genes With Schizophrenia in a Large European Ancestry Sample: Implications for Psychiatric Genetics

(2008) Alan R. Sanders et al.   AMERICAN JOURNAL OF PSYCHIATRY

The Dual-State Theory of Prefrontal Cortex Dopamine Function with Relevance to Catechol-O-Methyltransferase Genotypes and Schizophrenia

(2008) Daniel Durstewitz et al.   BIOLOGICAL PSYCHIATRY

Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia

(2008) Alessandro Bertolino et al.   BRAIN

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE